loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X

Technical details about UNII-MC34P30298, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Imipramine embonate, 10075-24-8, Imipramine (pamoate), Mc34p30298, 4,4'-methylenebis(3-hydroxy-2-naphthoic) acid, compound with 10,11-dihydro-n,n-dimethyl-5h-dibenz(b,f)azepine-5-propylamine (1:2), 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-n,n-dimethylpropan-1-amine
Molecular Formula
C61H64N4O6
Molecular Weight
949.2  g/mol
InChI Key
BPQZYOJIXDMZSX-UHFFFAOYSA-N
FDA UNII
MC34P30298

The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine
2.1.2 InChI
InChI=1S/C23H16O6.2C19H24N2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;2*1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2*3-6,8-11H,7,12-15H2,1-2H3
2.1.3 InChI Key
BPQZYOJIXDMZSX-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31.CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
MC34P30298
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4,4'-methylenebis(3-hydroxy-2-naphthoic Acid)-3-(10,11-dihydro-5h-dibenzo(b,f)azepin-5-yl)-n,n-dimethyl-1-propanamine (1:2)

2. Imidobenzyle

3. Imipramine

4. Imipramine Hydrochloride

5. Imipramine Monohydrochloride

6. Imizin

7. Janimine

8. Melipramine

9. Norchlorimipramine

10. Pryleugan

11. Tofranil

2.3.2 Depositor-Supplied Synonyms

1. Imipramine Embonate

2. 10075-24-8

3. Imipramine (pamoate)

4. Mc34p30298

5. 4,4'-methylenebis(3-hydroxy-2-naphthoic) Acid, Compound With 10,11-dihydro-n,n-dimethyl-5h-dibenz(b,f)azepine-5-propylamine (1:2)

6. 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid;3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-n,n-dimethylpropan-1-amine

7. Einecs 233-206-6

8. Unii-mc34p30298

9. Tofranil-pm (tn)

10. Imipramine Pamoate (usp)

11. 5h-dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-, Pamoate

12. Imipramine Pamoate [mi]

13. Chembl3989845

14. Schembl21834068

15. Dtxsid80143484

16. Imipramine Pamoate [vandf]

17. Imipramine Embonate [mart.]

18. Imipramine Pamoate [usp-rs]

19. Imipramine Embonate [who-dd]

20. Imipramine Pamoate [orange Book]

21. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With 10,11-dihydro-n,n-dimethyl-5h-dibenz(b,f)azepine-5-propanamine (1:2)

22. Imipramine Pamoate [usp Monograph]

23. Hy-107956

24. Cs-0030995

25. D08071

26. Q27283837

27. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With 10,11-dihydro-n,n-2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With 10,11-dihydro-n,n-dimethyl-5h-dibenz(b,f)azepine-5-propanamine (1:2)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 949.2 g/mol
Molecular Formula C61H64N4O6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count10
Rotatable Bond Count12
Exact Mass948.48258577 g/mol
Monoisotopic Mass948.48258577 g/mol
Topological Polar Surface Area128 Ų
Heavy Atom Count71
Formal Charge0
Complexity859
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Adrenergic Uptake Inhibitors

Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)


Antidepressive Agents, Tricyclic

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)


4.2 FDA Pharmacological Classification
4.2.1 Pharmacological Classes
Tricyclic Antidepressant [EPC]
Post Enquiry
POST ENQUIRY